{{Rsnum
|rsid=1803254
|Gene=CD33
|Chromosome=19
|position=51239889
|Orientation=plus
|GMAF=0.2029
|Gene_s=CD33
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 0.9 | 7.1 | 92.0
| HCB | 5.8 | 43.1 | 51.1
| JPT | 4.4 | 30.1 | 65.5
| YRI | 13.0 | 38.4 | 48.6
| ASW | 1.8 | 35.1 | 63.2
| CHB | 5.8 | 43.1 | 51.1
| CHD | 10.1 | 40.4 | 49.5
| GIH | 2.0 | 17.8 | 80.2
| LWK | 4.5 | 37.3 | 58.2
| MEX | 17.2 | 41.4 | 41.4
| MKK | 4.5 | 29.5 | 66.0
| TSI | 0.0 | 14.7 | 85.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=23444229
|Title=Clinical Significance of CD33 Nonsynonymous Single-Nucleotide Polymorphisms in Pediatric Patients with Acute Myeloid Leukemia Treated with Gemtuzumab-Ozogamicin-Containing Chemotherapy
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}